Literature DB >> 26207241

Stereotactic ablative radiotherapy and surgery: two gold standards for early-stage non-small cell lung cancer?

Hanbo Chen1, Alexander V Louie1.   

Abstract

There is growing clinical equipoise between surgery and stereotactic ablative radiotherapy (SABR) in the management of early-stage non-small cell lung cancer (ES-NSCLC). Increasing evidence suggest similar outcomes between these modalities. Through the guidance of a multidisciplinary team, a shared decision making approach in this setting in favoured.

Entities:  

Keywords:  Carcinoma; comparative effectiveness research; non-small cell lung; radiosurgery; retrospective studies; thoracic surgical procedures

Year:  2015        PMID： 26207241      PMCID： PMC4481359          DOI： 10.3978/j.issn.2305-5839.2015.05.08

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


  20 in total

1.  Impact of a multi-disciplinary patient education session on accrual to a difficult clinical trial: the Toronto experience with the surgical prostatectomy versus interstitial radiation intervention trial.

Authors:  Kris Wallace; Neil Fleshner; Michael Jewett; Joan Basiuk; Juanita Crook
Journal:  J Clin Oncol       Date:  2006-09-01       Impact factor: 44.544

2.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

3.  Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.

Authors:  Frank J Lagerwaard; Naomi E Verstegen; Cornelis J A Haasbeek; Ben J Slotman; Marinus A Paul; Egbert F Smit; Suresh Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-11-19       Impact factor: 7.038

4.  Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands.

Authors:  C J A Haasbeek; D Palma; O Visser; F J Lagerwaard; B Slotman; S Senan
Journal:  Ann Oncol       Date:  2012-05-02       Impact factor: 32.976

5.  Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer: a Markov model-based decision analysis.

Authors:  Alexander V Louie; George Rodrigues; Malek Hannouf; Gregory S Zaric; David A Palma; Jeffrey Q Cao; Brian P Yaremko; Richard Malthaner; Joseph D Mocanu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-06       Impact factor: 7.038

6.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

7.  Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.

Authors:  Shervin M Shirvani; Jing Jiang; Joe Y Chang; James Welsh; Anna Likhacheva; Thomas A Buchholz; Stephen G Swisher; Benjamin D Smith
Journal:  JAMA Surg       Date:  2014-12       Impact factor: 14.766

8.  Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer.

Authors:  Anand Shah; Stephen M Hahn; Robert L Stetson; Joseph S Friedberg; Taine T V Pechet; David J Sher
Journal:  Cancer       Date:  2013-05-29       Impact factor: 6.860

9.  Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  John A Howington; Matthew G Blum; Andrew C Chang; Alex A Balekian; Sudish C Murthy
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

Review 10.  Shared decision making: a model for clinical practice.

Authors:  Glyn Elwyn; Dominick Frosch; Richard Thomson; Natalie Joseph-Williams; Amy Lloyd; Paul Kinnersley; Emma Cording; Dave Tomson; Carole Dodd; Stephen Rollnick; Adrian Edwards; Michael Barry
Journal:  J Gen Intern Med       Date:  2012-05-23       Impact factor: 5.128
View more
  1 in total

1.  Gelsolin Promotes Radioresistance in Non-Small Cell Lung Cancer Cells Through Activation of Phosphoinositide 3-Kinase/Akt Signaling.

Authors:  Ru-Sen Zhao; Wei Wang; Jun-Ping Li; Chun-Mei Liu; Liya He
Journal:  Technol Cancer Res Treat       Date:  2016-04-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.